MTOR and pulmonary fibrosis: The phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)-dependent pathway is dysregulated in fibroproliferative diseases, like pulmonary fibrosis (Table 3) [172].